Publicaciones (161) Publicaciones de FELIX CARBONELL RAMON

2024

  1. In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease

    Frontiers in Aging Neuroscience, Vol. 16

  2. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease

    Communications Biology, Vol. 7, Núm. 1

2023

  1. Patient-specific models link neurotransmitter receptor mechanisms with motor and visuospatial axes of Parkinson’s disease

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Multivariate genomic and transcriptomic determinants of imaging-derived personalized therapeutic needs in Parkinson’s disease

    Scientific Reports, Vol. 12, Núm. 1

  2. Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease

    Brain, Vol. 145, Núm. 5, pp. 1785-1804

2021

  1. Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer’s disease

    eLife, Vol. 10

  2. Integrating molecular, histopathological, neuroimaging and clinical neuroscience data with NeuroPM-box

    Communications Biology, Vol. 4, Núm. 1

2020

  1. Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment

    Journal of Alzheimer's Disease, Vol. 73, Núm. 2, pp. 543-557

2019

  1. High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance

    Haematologica, Vol. 104, Núm. 11, pp. 2249-2257

  2. Rostral-Caudal Hippocampal Functional Convergence Is Reduced Across the Alzheimer’s Disease Spectrum

    Molecular Neurobiology, Vol. 56, Núm. 12, pp. 8336-8344

2018

  1. Mathematical modeling of protein misfolding mechanisms in neurological diseases: A historical overview

    Frontiers in Neurology, Vol. 9, Núm. FEB

  2. Multimodal imaging-based therapeutic fingerprints for optimizing personalized interventions: Application to neurodegeneration

    NeuroImage, Vol. 179, pp. 40-50

2017

  1. Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-art, challenges, and opportunities for studying brain chemistry

    Human Brain Mapping, Vol. 38, Núm. 4, pp. 2276-2325

  2. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes

    Cancer Letters, Vol. 409, pp. 42-48

  3. Cortical thickness abnormalities in autism spectrum disorders through late childhood, adolescence, and adulthood: A large-scale mri study

    Cerebral Cortex, Vol. 27, Núm. 3, pp. 1721-1731

  4. Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome

    Blood Transfusion, Vol. 15, Núm. 5, pp. 472-477

  5. Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer's disease

    NeuroImage, Vol. 152, pp. 60-77

  6. Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload

    Clinical Biochemistry, Vol. 50, Núm. 16-17, pp. 911-917

  7. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions

    Oncotarget, Vol. 8, Núm. 33, pp. 54297-54303

  8. Posterior dopamine D2/3 receptors and brain network functional connectivity

    Synapse, Vol. 71, Núm. 11